Chapter 1 Definition and Epidemiology of DM

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 28

Chapter 1

Definitions & Epidemiology of


Diabetes Mellitus
National Training on Management of Diabetes Mellitus
for Physicians

1
Objectives

• Define key terms in diabetes


• Describe the diagnostic criteria for DM
• Describe the global, regional and national
epidemiology of diabetes
• Explain risk factors, screening criteria and
preventive interventions of DM
Outline

• Definition of key terms


• DM diagnostic criteria
• Epidemiology of DM
• Risk factors, screening & preventive
interventions
• Summary
Activity 1.1: Individual
Refection
Instruction: Read and reflect individually the following
questions.
1. How do you explain the definition of diabetics for a
patient?
2. What does ‘’defective insulin secretion’’ and “insulin
resistance” mean?
Time: 5 minutes
1.1 Definition of Key Terms
Diabetes
• A metabolic disorder-disturbances of
carbohydrate, fat and protein metabolism

• Characterized by chronic hyperglycemia

• Resulting from defects in insulin secretion,


insulin action, or both

• Marked propensity to develop renal, ocular,


neurologic, and premature cardiovascular
diseases
1.1 Definition of Key Terms
(2)
Defective insulin secretion
• Inadequate compensatory increase of β-cell
mass
• Impaired glucose-dependent insulin release

Insulin resistance
• Inability insulin to increase glucose uptake
and utilization
1.2 DIAGNOSIS of DM
• DM is diagnosed by laboratory measurement of
glucose or glycosylated haemoglobin level in
a blood sample.

• Fasting blood glucose is likely to be the most


feasible measurement in PHC facilities.
1.2 Diagnosis of DM
• Be certain about diagnosis.

• Consequences: considerable & lifelong.

• Hyperglycemia may be transitory.

• In asymptomatic individuals: at least 2


tests.

• Do not make diagnosis based on single


elevation of FBS.
• Exception – DHA & HHS

• Urine glucose: not recommended.


Diagnostic Criteria for DM

WWW.DIABETES.ORG/DIABETESCARE Volume 39, Supplement 1, January 2016


Prediabetes
• IGT: 140 < 2-hr PG < 200 mg/dl
• IFG: 100 < FBS < 126 mg/dl

• Why is Prediabetes important?


• Risk for future diabetes
• Risk for macrovascular diseases
1.3 Epidemiology of DM
• Diabetes is one of the largest global health
emergencies of the 21st century.

• It is in a state of global epidemic affecting


every country, age group and economy.

• DM and its complications are major cause for


early death in most countries
• Cardiovascular death is leading cause in diabetic
population.
Diabetes around the
world: IDF 2021
• 537 million adults (20-79 years) are living with
diabetes: 1 in 10

• This number is predicted to rise to

• 643 million by 2030 and

• 783 million by 2045

• Over 3 in 4 adults with diabetes live in low- and


middle-income countries
Diabetes Around the World:
IDF 2021
• 6.7 million deaths in 2021
• 1 every 5 seconds

• Caused at least USD 966 billion dollars in


health expenditure
• 316% increase over the last 15 years

• 541 million adults have IGT


• Places them at high risk of type 2 diabetes
Diabetes in Africa: IDF
2021
• 24 million adults are living with diabetes.

• 1 in 22 adults

• This number is predicted to increase by 129% to 55 million by 2045

• Over 1 in 2 (54%) people living with diabetes are undiagnosed

• Diabetes is responsible for 416,000 deaths in 2021.

• 1 in 8 live births are affected by hyperglycemia in pregnancy


Diabetes in Ethiopia
• Few local data on the prevalence of diabetes in Ethiopia
• Ayder Hospial, Mekele: 1.3%
• Gondar and Dabat: 5.1% for urban and 2.1% for
rural
• Bank employees and teachers: 6.5 %
• National NCD STEPS Survey 2015
• Prevalence of DM (FBS 126 mg /dl) including those
on medication was 3.2%
• The prevalence of IFG: 9.1% with ADA criteria
Diabetes in Ethiopia: IDF 2021
Diabetes estimates (20-79 y) 2000 2011 2021 2030 2045
People with diabetes, in 268.1 1377.3 1920.00 2740.80 4755.50
1,000s
Age-adjusted comparative 3.4 5 5.3 5.4
prevalence of diabetes, %
People with undiagnosed 1105.9
diabetes, in 1,000s
Proportion of people with 57.6
undiagnosed diabetes, %
People with IGT, in 1,000s 3266.5 7140.7 10018.1 17391.5
Age-adjusted comparative 8.9 19.2 21.2 22.5
prevalence of IGT, %
People with IFG, in 1,000s 3077.5 4805.4 7625.5
Age-adjusted comparative 6.7 7.4 7.4
prevalence of IFG, %
Diabetes in Ethiopia: IDF
2021
Type 1 diabetes estimates 2000 2011 2021 2030 2045
in children and
adolescents
Type 1 diabetes (0-14 y), in 0.5 0.6
1,000s
Live births affected by HIP 2986848
Prevalence of gestational 15.1
diabetes mellitus (GDM), %
Total diabetes-related 200.2 281.2 452.4
health expenditure, USD
million
Diabetes-related health 25 104.3 146.4 235.6
expenditure per person,
USD
Activity 1.2: Group Discussion

Instruction: Read and discuss the following


questions in groups and present to the plenary.

1. What are the risk factors for diabetes?


2. What screening criteria is used for diabetes in
resource limited settings?
3. What preventive measures are recommended to
prevent/delay diabetes?

Time: 10 minutes
18
Risk Factors for DM
• DM shares common Risk factors with Major
NCDs.

Others:
• Urban-rural migration
• Increasing population
• Increasing Age
• Stress
DM Screening: Imperatives
• The high prevalence of undiagnosed Type 2
diabetes
• High proportion of patients with complications
at diagnosis
• Presence of preventive interventions
DM Screening: Criteria
1.Adults: overweight (BMI>25 kg/m2 ) plus
additional risk factors:
• Physical inactivity
• First-degree relative with diabetes
• Members of a high-risk ethnic population:
African Americans, Asians, native Americans
• women who delivered a baby > 4kg or
diagnosed as GDM
• Hypertension (BP 140/90mmHg or on
therapy)
DM Screening: Criteria (2)
• HDL <35 mg/dl and or TG >250 mg/dl
• A1C >5.7 %, IGT, or IFG on previous testing
• History of CVD
• Women with polycystic ovarian syndrome

All patients at age of 45 years


DM Screening: Criteria (3)
2. Children ≥ 10 years or at onset of puberty
who are overweight with any two of the
following:
• DM in first or second degree relative
• Signs of insulin resistance: Acanthosis
nigricans, severe obesity
• Maternal DM or GDM during child’s gestation

• ‘Normal’ results: repeat at a 3-year intervals


• ‘Prediabetes’: repeat yearly
Preventive Inventions

• Delays the onset of diabetes

• Preserves beta cell function

• Prevents or delays microvascular and


cardiovascular complications
Preventive Interventions (2)

I. Lifestyle Modifications
Preventive Interventions (3)

II: Metformin therapy


• For prediabetes, especially in those with BMI >35
kg/m2
• Aged <60 years
• Women with prior GDM

III. Annual monitoring for the development of


diabetes in those with prediabetes

IV. Screening for and treatment of modifiable


risk factors for CVD
Summary
 DM is a metabolic disorder resulting from defects in
insulin secretion, insulin action, or both
 DM is diagnosed by measurement of FBG for A1C
levels
 Diabetes is in a state of global epidemic affecting
every country, every age group and every economy
 The major risk factors for diabetes are modifiable
 Screening and prevention delays Type 2 DM and
prevents complications
 There are evidence-based lifestyle
recommendations for prevention of Type 2 DM
27
Thank You

28

You might also like